| The ever-evolving concept of the cancer stem cell in pancreatic cancer S Valle, L Martin-Hijano, S Alcalá, M Alonso-Nocelo, B Sainz Jr Cancers 10 (2), 33, 2018 | 140 | 2018 |
| Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment L Muinelo-Romay, M Vieito, A Abalo, M Alonso Nocelo, F Barón, U Anido, ... Cancers 6 (1), 153-165, 2014 | 126 | 2014 |
| Molecular characterization of circulating tumor cells in human metastatic colorectal cancer J Barbazan, L Alonso-Alconada, L Muinelo-Romay, M Vieito, A Abalo, ... PloS one 7 (7), e40476, 2012 | 115 | 2012 |
| Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells S Valle, S Alcalá, L Martin-Hijano, P Cabezas-Sáinz, D Navarro, ... Nature Communications 11 (1), 5265, 2020 | 106 | 2020 |
| Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells M Alonso-Nocelo, TM Raimondo, KH Vining, R López-López, ... Biofabrication 10 (3), 035004, 2018 | 96 | 2018 |
| Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance G D’Errico, M Alonso-Nocelo, M Vallespinos, PC Hermann, S Alcalá, ... Oncogene, 2019 | 72 | 2019 |
| High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion L Muinelo-Romay, E Colas, J Barbazan, L Alonso-Alconada, ... Molecular cancer therapeutics 10 (8), 1357-1366, 2011 | 66 | 2011 |
| Polyarginine nanocapsules: a new platform for intracellular drug delivery MV Lozano, G Lollo, M Alonso-Nocelo, J Brea, A Vidal, D Torres, ... Journal of nanoparticle research 15, 1-14, 2013 | 64 | 2013 |
| Biocompatible iron (III) carboxylate metal–organic frameworks as promising RNA nanocarriers T Hidalgo, M Alonso-Nocelo, BL Bouzo, S Reimondez-Troitiño, ... Nanoscale 12 (8), 4839-4845, 2020 | 63 | 2020 |
| Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma M Alonso-Nocelo, L Ruiz-Cañas, P Sancho, K Görgülü, S Alcalá, ... Gut 72 (2), 345-359, 2023 | 51 | 2023 |
| A multifunctional drug nanocarrier for efficient anticancer therapy C Teijeiro-Valiño, R Novoa-Carballal, E Borrajo, A Vidal, ... Journal of Controlled Release 294, 154-164, 2019 | 45 | 2019 |
| A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer J Barbazán, M Vieito, A Abalo, L Alonso‐Alconada, L Muinelo‐Romay, ... Journal of cellular and molecular medicine 16 (10), 2342-2349, 2012 | 32 | 2012 |
| Molecular profiling of circulating tumour cells identifies Notch1 as a principal regulator in advanced non-small cell lung cancer J Mariscal, M Alonso-Nocelo, L Muinelo-Romay, J Barbazan, M Vieito, ... Scientific reports 6 (1), 37820, 2016 | 29 | 2016 |
| Development and characterization of a three-dimensional co-culture model of tumor T cell infiltration M Alonso-Nocelo, C Abuín, R López-López, M De La Fuente Biofabrication 8 (2), 025002, 2016 | 26 | 2016 |
| Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node M Alonso-Nocelo, R Abellan-Pose, A Vidal, M Abal, N Csaba, MJ Alonso, ... Journal of nanobiotechnology 14, 1-9, 2016 | 16 | 2016 |
| Tumor invasion and oxidative stress: biomarkers and therapeutic strategies L Muinelo-Romay, L Alonso-Alconada, M Alonso-Nocelo, J Barbazan, ... Current Molecular Medicine 12 (6), 746-762, 2012 | 11 | 2012 |
| Nanotheranostics and their potential in the management of metastatic cancer M Alonso-Nocelo, BL Bouzo, J Ruiz-Bañobre, M de la Fuente Handbook of nanomaterials for cancer theranostics, 199-244, 2018 | 3 | 2018 |
| Correction: Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma M Alonso-Nocelo, L Ruiz-Cañas, P Sancho Gut 73, e21, 2024 | | 2024 |
| Engineering 3D cell culture models for cancer research MA Nocelo Universidade de Santiago de Compostela, 2016 | | 2016 |
| Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment U Anido Herranz, M Vieito Villar, A Abalo Piñeiro, L Muinelo Romay, ... | | 2014 |
Jorge BarbazanHealth Research Institute of Santiago de Compostela.Verified email at curie.fr
